DL

Greenhouse Gases in Oceans Are Altered by Climate Change Impact on Microbes - An Incheon National University Study

Retrieved on: 
Donnerstag, Dezember 7, 2023
The Marine Pollution Bulletin, Carbon, Associate, OD, Research, Climate change, Greenhouse, Nitrous oxide, OW, Ecosystem, OA, Methane, DL, Oceanography, AND, CH4, Incheon National University, Seaweed, N2O

GWANGJU, South Korea, Dec. 7, 2023 /PRNewswire/ -- The ocean is a global life-support system, and climate change causes such as ocean warming, acidification, deoxygenation, and nitrogen-deposition alter the delicate microbial population in oceans. The marine microbial community plays an important role in the production of greenhouse gases like nitrous oxide and methane. Scientists at Incheon National University have explored the climate change impact on marine microbes. Their research helps raise awareness about climate change severity and the importance of ocean resources.

Key Points: 
  • The marine microbial community plays an important role in the production of greenhouse gases like nitrous oxide and methane.
  • Scientists at Incheon National University have explored the climate change impact on marine microbes.
  • Their research helps raise awareness about climate change severity and the importance of ocean resources.
  • "Climate change leads to marine environmental changes and this study can enhance our understanding of their impact on human life," Prof. Kim says.

High Performance Computing for Automotive

Retrieved on: 
Donnerstag, Dezember 7, 2023
Embedded, GPU, Classification, Electric car, Computer, Acquisition, Policy, Personal computer, Acceleration, Socs, PCB, Traction, Semiconductor, 2600-series (CTA), Element, Algorithm, Artificial intelligence, Intel, Central processing unit, TSMC, RAM, Graphics processing unit, CPU, Mobileye, NVIDIA, SOC, DL, 2D, Neural network, SAE, HPC, AMD, Deep learning, Autonomy, Torque, ICS, 3D, 2000s, ADAS, Sensor, Fin field-effect transistor, Silicon, Noise, Environment, Renesas Electronics, Samsung, Transport, Instrumentation, Video game, Nvidia

However, sensors alone are next to useless without high performance computing processing their data and constructing a 3D rendering of the environment to inform the vehicle's programmed driving policy.

Key Points: 
  • However, sensors alone are next to useless without high performance computing processing their data and constructing a 3D rendering of the environment to inform the vehicle's programmed driving policy.
  • High performance computing (HPC) takes the real-time data outputs from the array of sensors and performs several important processes.
  • As such, automotive HPC developers need to think about how they can optimize existing technologies to get the most performance.
  • With increasing demand for high performance computing in vehicles and a necessity for continual performance growth, there will be a rapid evolution in the technology that goes into automotive computers.

High Performance Computing for Automotive

Retrieved on: 
Donnerstag, Dezember 7, 2023
Embedded, GPU, Classification, Electric car, Computer, Acquisition, Policy, Personal computer, Acceleration, Socs, PCB, Traction, Semiconductor, 2600-series (CTA), Element, Algorithm, Artificial intelligence, Intel, Central processing unit, TSMC, RAM, Graphics processing unit, CPU, Mobileye, NVIDIA, SOC, DL, 2D, Neural network, SAE, HPC, AMD, Deep learning, Autonomy, Torque, ICS, 3D, 2000s, ADAS, Sensor, Fin field-effect transistor, Silicon, Noise, Environment, Renesas Electronics, Samsung, Transport, Instrumentation, Video game, Nvidia

However, sensors alone are next to useless without high performance computing processing their data and constructing a 3D rendering of the environment to inform the vehicle's programmed driving policy.

Key Points: 
  • However, sensors alone are next to useless without high performance computing processing their data and constructing a 3D rendering of the environment to inform the vehicle's programmed driving policy.
  • High performance computing (HPC) takes the real-time data outputs from the array of sensors and performs several important processes.
  • As such, automotive HPC developers need to think about how they can optimize existing technologies to get the most performance.
  • With increasing demand for high performance computing in vehicles and a necessity for continual performance growth, there will be a rapid evolution in the technology that goes into automotive computers.

Applicant Tracking Systems Market in Europe to USD 202.48 million growth between 2022 - 2027 | Growth Driven by Digitalization of HR divisions of organizations - Technavio

Retrieved on: 
Montag, November 27, 2023
Key (company), Applicant (sketch), ATS, Organization, CVS, ISO, USD, Machine learning, DL, Deep learning, HR, Growth, ISO 9001:2015, Workload, Certification, Speciality chemicals

The potential growth difference for the applicant tracking systems market in Europe between 2022 and 2027 is USD 202.48 million.

Key Points: 
  • The potential growth difference for the applicant tracking systems market in Europe between 2022 and 2027 is USD 202.48 million.
  • Buy the full report here
    Market Challenge - Keyword optimization issues in applicant tracking systems hinder market growth.
  • Key Companies in the Applicant Tracking Systems Market in Europe:
    The US - applicant tracking (ATS) systems market size is estimated to grow at a CAGR of 5.31% between 2022 and 2027.
  • The applicant tracking systems (ATS) market size is estimated to grow at a CAGR of 5.69% between 2022 and 2027.

United Imaging Intelligence to Unveil Cutting-edge AI Technology at RSNA

Retrieved on: 
Mittwoch, November 22, 2023
RSNA, Research, UII, Theatre, Cardiology, Deep learning, CAD, Neurology, Artificial intelligence, DL, Coronary artery disease, 3D, Health, AI, Radiology, Public, Medical device, Medical imaging

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- United Imaging Intelligence (UII), a pioneering subsidiary of United Imaging Group known for its innovative artificial intelligence (AI) applications in healthcare, is set to showcase its latest medical AI advancements at the upcoming Radiological Society of North America (RSNA) meeting in Chicago.

Key Points: 
  • SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- United Imaging Intelligence (UII), a pioneering subsidiary of United Imaging Group known for its innovative artificial intelligence (AI) applications in healthcare, is set to showcase its latest medical AI advancements at the upcoming Radiological Society of North America (RSNA) meeting in Chicago.
  • Amidst the rapid evolution of AI in healthcare, UII's commitment to industry-academia-medical collaboration has been crucial in developing practical AI applications for clinical settings.
  • A prime example of UII's groundbreaking work addresses the public health challenge of Coronary Artery Disease (CAD) detection.
  • says Dr. Terrence Chen, CEO of United Imaging Intelligence America.

Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting

Retrieved on: 
Donnerstag, November 2, 2023
FDA, DSM-IV codes, Translation, Fred Hutchinson Cancer Research Center, Infrared spectroscopy correlation table, Bone marrow, University of Washington, Disclosure, Chronic lymphocytic leukemia, Waldenström, Society, PET-CT, Disease, Cancer, Follicular lymphoma, Mustang, University, DL, NHL, Safety, Patient, Investigational New Drug, Associate, American Society of Hematology, HCL, Lymphoma, Pharmaceutical industry, WM

MB-106 is being developed in a collaboration between Mustang and Fred Hutchinson Cancer Center (“Fred Hutch”).

Key Points: 
  • MB-106 is being developed in a collaboration between Mustang and Fred Hutchinson Cancer Center (“Fred Hutch”).
  • All patients displayed MB-106 expansion, with peak levels between 7-14 days post-infusion, and CAR-T cell persistence is ongoing at 6 months.
  • From a safety perspective, 3 patients experienced Grade 1 cytokine release syndrome and no occurrences of immune effector cell-associated neurotoxicity syndrome were reported.
  • Dose-limiting toxicities (“DLT”) were monitored through day 28, and no DLTs were observed at DL1.

Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update

Retrieved on: 
Donnerstag, November 2, 2023
First grade, Research, HS, AD, PD, Food, Safety, Dana–Farber Cancer Institute, Disease, Abstract, Immunology, Cutaneous T-cell lymphoma, Uveal melanoma, STAT3, International, Physician, GDF15, Webcast, Atopic dermatitis, Therapy, Investment, CTCL, Patient, Administration, Cash, Plasma, Lymphoma, Conference, IRAK4, Development, TPD, ASH, Growth, DL2, Hypotension, DL, Solar cycle 4, Arm, AACR, Thrombocytopenia, Fast Track, PTCL, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, R, Society, SD, Hidradenitis suppurativa, MDM2, Recurrence, Blood, Peripheral T-cell lymphoma, Neutropenia, AML, Merkel-cell carcinoma, Pharmaceutical industry, Vaccine, Fine chemical, Medical device, Angela Merkel, Sanofi, Black Majesty

ET

Key Points: 
  • ET
    WATERTOWN, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today reported financial results for the third quarter ended September 30, 2023, and provided business updates on its pipeline of protein degraders.
  • Collaboration Revenues: Collaboration revenues were $4.7 million for the third quarter of 2023 compared to $9.6 million for the third quarter of 2022.
  • Net Loss: Net loss was $52.9 million for the third quarter of 2023 compared to a net loss of $43.0 million for the third quarter of 2022.
  • Cash and Cash Equivalents: As of September 30, 2023, Kymera had $435 million in cash, cash equivalents, and investments.

Kymera Therapeutics to Present New Clinical Data from the Phase 1 Trial of STAT3 Degrader KT-333 at the ASH Annual Meeting

Retrieved on: 
Donnerstag, November 2, 2023
Cutaneous T-cell lymphoma, Patient, STAT3, PD, Fatigue, Human, PTCL, Factorization of polynomials, Nausea, Society, ASH, DL2, Relapse, Blood, Anemia, Peripheral T-cell lymphoma, Exposition, DL, Safety, Therapy, CTCL, Toxicity, Pharmaceutical industry, Vaccine, Pharmacokinetics

WATERTOWN, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, today announced that new KT-333 Phase 1 data highlighting safety, pharmacokinetics (PK), pharmacodynamics (PD) and clinical responses will be presented at the ASH 65th Annual Meeting and Exposition, taking place from December 9-12, 2023, in San Diego, California. Results released in an ASH abstract today include data as of a July 10, 2023 cut-off. The poster presentation is expected to include additional data, including PK/PD, safety and results of disease response assessments from additional patients subsequent to the abstract cut-off date. In addition, preclinical data will be presented supporting the potential of STAT3 protein degraders as a therapeutic approach in venetoclax-resistant Acute Myeloid Leukemia.

Key Points: 
  • Results released in an ASH abstract today include data as of a July 10, 2023 cut-off.
  • The poster presentation is expected to include additional data, including PK/PD, safety and results of disease response assessments from additional patients subsequent to the abstract cut-off date.
  • In addition, preclinical data will be presented supporting the potential of STAT3 protein degraders as a therapeutic approach in venetoclax-resistant Acute Myeloid Leukemia.
  • Title: Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Bloomberg Collaborates with Google Cloud to Accelerate Innovation in Data Management and Analytics

Retrieved on: 
Freitag, November 3, 2023
Cloud, Intelligence, Publishing, BigQuery, ESG, Mackenzie Investments, Organization, Acquisition, Google Cloud, Research, Environment, Enterprise data planning, DL, Google Cloud Platform, Collection, Micro ISV, Network equipment provider, Cryptocurrency, Security (finance), Bloomberg

NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Bloomberg today announced a new offering that enables customers of Google Cloud to accelerate their data strategies through the integration of Bloomberg's cloud-based data management solution, Data License Plus (DL+), with BigQuery, Google Cloud's fully managed, serverless data warehouse.

Key Points: 
  • Bloomberg Enterprise Data content and Data License Plus are now integrated with BigQuery, enabling customers to easily bring comprehensive datasets to their analytics workloads
    NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Bloomberg today announced a new offering that enables customers of Google Cloud to accelerate their data strategies through the integration of Bloomberg's cloud-based data management solution, Data License Plus (DL+), with BigQuery, Google Cloud's fully managed, serverless data warehouse.
  • "We're excited to expand our collaboration with Google Cloud, remaining at the forefront of innovation in financial data management and further expanding our customers' enterprise analytics capabilities."
  • Access to Bloomberg data directly in BigQuery: Bloomberg customers can now seamlessly access Bloomberg Data License content within BigQuery for scalable use throughout their enterprise, accelerating time-to-value from analytics projects by eliminating the time-consuming process of ingesting and structuring third-party datasets.
  • Eliminated data barriers: Bloomberg and Google Cloud will make Bloomberg's DL+ solution available to mutual customers via BigQuery, allowing for the delivery of fully modeled Bloomberg data and multi-vendor ESG content that is accessible within their analytics workloads.

Twenty-one grants awarded to support trainees across Canada

Retrieved on: 
Mittwoch, Oktober 25, 2023
Linda, Research, Health Canada, Glioblastoma, Doctor of Philosophy, Local government in Canada, Hospital for Sick Children, Travel, Gonda Multidisciplinary Brain Research Center, Hospital, Commonwealth Associates, Inc., INRS, ICRM, Henry, Directory, Institut national de la recherche scientifique, Consortium, University of British Columbia, University, MD, Dalhousie University, University of Victoria, Mireille, DL, York University, University Health Network, Cannabinoid Research Initiative of Saskatchewan, ALS, Nursing, Mobile phone, Pharmaceutical industry, Canning, Brain, Master of Science, Cannabinoid, Friends, Cannabis

MONTREAL, Oct. 25, 2023 (GLOBE NEWSWIRE) -- In an effort to support the next generation of brain researchers in Canada, Brain Canada is thrilled to present the 21 trainees who have received grants to help launch their academic careers and pursue their professional goals. The Brain Canada Rising Stars Trainee Awards aim to recognize the excellent research being conducted at Canadian institutions by graduate students (M.Sc., Ph.D.), postdoctoral fellows, and medical residents in all fields spanning neuroscience research.

Key Points: 
  • MONTREAL, Oct. 25, 2023 (GLOBE NEWSWIRE) -- In an effort to support the next generation of brain researchers in Canada, Brain Canada is thrilled to present the 21 trainees who have received grants to help launch their academic careers and pursue their professional goals.
  • “Supporting trainees through specialized programs designed for the next generation of scholars is a fundamental aspect of Brain Canada's mission,” says Dr. Viviane Poupon, President and CEO of Brain Canada.
  • "We are delighted to announce the expansion of our support through the Brain Canada Rising Stars Trainee Awards this year, demonstrating our commitment to nurturing the next era of exceptional brain researchers."
  • "Brain Canada's support of trainees and early career researchers is clearly responding to a need, and the continued commitment to enable capacity-building programs is more important now than ever."